An underground economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to message these accounts privately for supplier links, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Professionals Express Concerns
However, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could result in users injecting products of unknown origin.
Several professionals said the popularity for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.
Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, marketing, and customer laws, risking fines, prosecution or imprisonment.
Service Response and Content Removal
According to TikTok, the platform has removed problematic material and banned associated keywords and query recommendations. The company said it was committed to keeping the service secure and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Research also found groups with up to nine thousand members marketing the experimental drug using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or administering at home.
Within minutes of joining one group, a vendor posted contact information, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.
Item Information and Costs
Within these groups, posts display black plastic parcels with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20mg. When asked how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service said it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.
Her team has previously seen individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly serious health risks”.
